BioVectra Is An Emerging Force In Pharmaceutical Manufacturing In Canada
BioVectra plans to build a facility on P.E.I that will eventually manufacture enough doses of mRNA vaccines to supply all of Canada. On the latest 'Insights' podcast, CEO Oliver Technow talks about the recent announcement that shines a light on a 50-year old company that employs more than 550 people in P.E.I. and Nova Scotia.
BioVectra plans to build a facility on Prince Edward Island that will eventually manufacture enough doses of mRNA vaccines to supply all of Canada, which is big news for Canadians as well as Atlantic Canadians. The recent announcement shines a light on a 50-year old company that employs more than 550 people in P.E.I. and Nova Scotia.
"There are 35 million-plus Canadians. We could probably within a year single-handedly make sure the demand for Canada has been taken care of if we were the ones to produce the vaccine in the future," says company CEO Oliver Technow.
On this episode of the "Insights" podcast, Technow speaks with co-host Don Mills about the origins of the company and the original vision of its founder Regis Duffy, and how the company has grown over the decades to its present capabilities.
